[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100544176":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":26,"centralContacts":30,"locations":35,"responsibleParty":47,"collaborators":25,"id":49,"slug":50,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":25,"eligibilityCriteria":55,"healthyVolunteers":51,"sex":56,"minAge":57,"maxAge":25,"enrollmentInfo":58,"targetDuration":25,"studyType":61,"phases":62,"briefSummary":64,"conditions":65,"keywords":68,"overallStatus":38,"whyStopped":25,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":83},{"fullName":5,"class":6},"National Taiwan University Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Focused Extracorporeal Shock Wave Therapy","EXPERIMENTAL","Participants in this arm will receive focused Extracorporeal Shock Wave Therapy (ESWT) targeting three specific muscles: the flexor carpi ulnaris, flexor carpi radialis, and flexor digitorum superficialis. Each muscle will receive 1,500 shockwave shots per session, accumulating to a total of 4,500 shots across all targeted muscles in each session. The treatment will be administered twice a week for two consecutive weeks, resulting in a total of four treatment sessions.",[13],"Device: focused extracorporeal shock wave therapy (ESWT)",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo-Controlled Shockwave Therapy","PLACEBO_COMPARATOR","Participants in this arm will receive placebo-controlled focused ESWT, mirroring the treatment protocol of the experimental group but without the application of active shockwaves.",[13],[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DEVICE","focused extracorporeal shock wave therapy (ESWT)","The focused shockwaves are directed at the affected muscles in the upper limb, specifically targeting the flexor carpi ulnaris, flexor carpi radialis, and flexor digitorum superficialis.",[9,15],null,[27],{"name":28,"affiliation":5,"role":29},"Shu-mei Yang, MD","PRINCIPAL_INVESTIGATOR",[31],{"name":28,"role":32,"phone":33,"phoneExt":25,"email":34},"CONTACT","886-0972653754","b99401109@gmail.com",[36],{"facility":37,"status":38,"city":39,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":25,"geoPoint":25,"contacts":43},"Department of Physical Medicine & Rehabilitation , National Taiwan University Hospital","RECRUITING","Taipei","100","Taiwan","TW",[44,46],{"name":28,"role":32,"phone":45,"phoneExt":25,"email":34},"886-2- 23123456",{"name":28,"role":29,"phone":25,"phoneExt":25,"email":25},{"type":48,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100544176","flexwave-trial-efficacy-of-extracorporeal-shock-wave-therapy-in-post-stroke-upper-limb-spasticity-100544176",false,"NCT06365476","FlexWave Trial: Efficacy of Extracorporeal Shock Wave Therapy in Post-Stroke Upper Limb Spasticity","Effects of Extracorporeal Shock Wave for Upper Limb Flexor Spasticity in Stroke Patients: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Individuals aged 18 years or older with unilateral cerebral stroke.\n* Wrist and finger flexor muscle tone with a score greater than 1 on the Modified Ashworth Scale.\n* Stable medical condition and vital signs.\n* Conscious and able to comply with instructions.\n\nExclusion Criteria:\n\n* History of more than one stroke, traumatic brain injury, or cerebral neoplasm.\n* Coexisting central nervous system disorders (e.g., spinal cord injury, Parkinson's disease) or other musculoskeletal diseases affecting muscle tone assessment.\n* Contraindications for shockwave intervention, such as malignancies, coagulopathies, local infections, or use of cardiac pacemakers.\n* Undergone shockwave therapy or botulinum toxin injections for post-stroke spasticity in the past three months.\n* Cognitive, consciousness, or language impairments preventing participation in the intervention or functional assessments.","ALL","18 Years",{"count":59,"type":60},40,"ESTIMATED","INTERVENTIONAL",[63],"NA","Extracorporeal shock wave therapy (ESWT) has emerged as an effective therapeutic intervention for addressing post-stroke limb spasticity. This research aims to explore the therapeutic implications of focused ESWT for wrist and finger flexor muscles in patients suffering from post-stroke upper limb spasticity.",[66,67],"Stroke","Spasticity, Muscle",[69,70,71,72,73],"stroke","spasticity","shock wave","wrist","finger","2025-07-27",{"date":76,"type":77},"2025-07-29","ACTUAL",{"date":79,"type":77},"2024-04-15",{"date":81,"type":60},"2027-04-15",{"name":5,"class":6},1]